APTA vs. OKYO, AOR, SAR, POLB, AREC, RLM, OPTI, NSCI, IXI, and IMM
Should you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include OKYO Pharma (OKYO), AorTech International (AOR), Sareum (SAR), Poolbeg Pharma (POLB), Arecor Therapeutics (AREC), Realm Therapeutics (RLM), OptiBiotix Health (OPTI), NetScientific (NSCI), IXICO (IXI), and ImmuPharma (IMM). These companies are all part of the "biotechnology" industry.
Aptamer Group vs. Its Competitors
OKYO Pharma (LON:OKYO) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.
11.7% of Aptamer Group shares are held by institutional investors. 31.9% of OKYO Pharma shares are held by company insiders. Comparatively, 13.2% of Aptamer Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
OKYO Pharma has a net margin of 0.00% compared to Aptamer Group's net margin of -343.95%. Aptamer Group's return on equity of -205.63% beat OKYO Pharma's return on equity.
OKYO Pharma has higher earnings, but lower revenue than Aptamer Group. Aptamer Group is trading at a lower price-to-earnings ratio than OKYO Pharma, indicating that it is currently the more affordable of the two stocks.
In the previous week, OKYO Pharma's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score.
OKYO Pharma received 7 more outperform votes than Aptamer Group when rated by MarketBeat users.
OKYO Pharma has a beta of -0.06, indicating that its share price is 106% less volatile than the S&P 500. Comparatively, Aptamer Group has a beta of -0.52, indicating that its share price is 152% less volatile than the S&P 500.
Summary
OKYO Pharma beats Aptamer Group on 6 of the 11 factors compared between the two stocks.
Get Aptamer Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding APTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptamer Group Competitors List
Related Companies and Tools
This page (LON:APTA) was last updated on 6/13/2025 by MarketBeat.com Staff
Buy APTA Stock Free APTA Stock Alerts